PT

Philip E. Thorpe

University Of Texas System: 57 patents #2 of 6,559Top 1%
SR Scripps Research: 5 patents #168 of 1,293Top 15%
TR The Universty Of Texas System,Board Of Regents: 2 patents #4 of 109Top 4%
PP Peregrine Pharmaceuticals: 2 patents #4 of 17Top 25%
UT University Of Texas: 1 patents #37 of 278Top 15%
IT Imperial Cancer Research Technology: 1 patents #35 of 66Top 55%
📍 London, TX: #2 of 86 inventorsTop 3%
Overall (All Time): #33,007 of 4,157,543Top 1%
66
Patents All Time

Issued Patents All Time

Showing 51–66 of 66 patents

Patent #TitleCo-InventorsDate
6093399 Methods and compositions for the specific coagulation of vasculature Thomas S. Edgington 2000-07-25
6051230 Compositions for targeting the vasculature of solid tumors Francis Burrows 2000-04-18
6036955 Kits and methods for the specific coagulation of vasculature Thomas S. Edgington 2000-03-14
6004554 Methods for targeting the vasculature of solid tumors Francis Burrows 1999-12-21
6004555 Methods for the specific coagulation of vasculature Thomas S. Edgington 1999-12-21
5965132 Methods and compositions for targeting the vasculature of solid tumors Francis Burrows 1999-10-12
5877289 Tissue factor compositions and ligands for the specific coagulation of vasculature Thomas S. Edgington 1999-03-02
5863538 Compositions for targeting the vasculature of solid tumors Francis Burrows 1999-01-26
5855866 Methods for treating the vasculature of solid tumors Francis Burrows 1999-01-05
5776427 Methods for targeting the vasculature of solid tumors Francis Burrows 1998-07-07
5762918 Methods of using steroid-polyanionic polymer-based conjugated targeted to vascular endothelial cells 1998-06-09
5660827 Antibodies that bind to endoglin Francis Burrows 1997-08-26
5474765 Preparation and use of steroid-polyanionic polymer-based conjugates targeted to vascular endothelial cells 1995-12-12
5338542 Disulfide linked immunotoxins with molecular groupings in the linker which cause steric hindrance to the disulfide linkage 1994-08-16
5165923 Methods and compositions for the treatment of Hodgkin's disease Andreas Engert 1992-11-24
4880935 Heterobifunctional linking agents derived from N-succinimido-dithio-alpha methyl-methylene-benzoates 1989-11-14